We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.74%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$61.7B
AUM Growth
+$546M
(+0.89%)
Cap. Flow
-$4.01B
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
23.47%
Holding
1,295
New
145
Increased
379
Reduced
411
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$218M |
| 2 |
Bank of America
BAC
|
+$205M |
| 3 |
Dollar General
DG
|
+$198M |
| 4 |
Union Pacific
UNP
|
+$197M |
| 5 |
Elevance Health
ELV
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$505M |
| 2 |
Rockwell Automation
ROK
|
+$373M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$294M |
| 4 |
eBay
EBAY
|
+$222M |
| 5 |
TSMC
TSM
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.38% |
| 2 | Healthcare | 15.97% |
| 3 | Financials | 13.78% |
| 4 | Industrials | 11.75% |
| 5 | Communication Services | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
American Express
AXP
$227B
| $62M | 0.1% |
502,000
+20,062
| +4% | +$2.36M |
|
152
Bristol-Myers Squibb
BMY
$130B
| $59.1M | 0.1% |
1,303,480
+102,511
| +9% | +$4.77M |
|
153
Brixmor Property Group
BRX
$9.77B
| $58M | 0.09% |
3,241,483
+150,183
| +5% | +$2.7M |
|
154
Banco Macro
BMA
$5.81B
| $57.9M | 0.09% |
795,337
+45,014
| +6% | +$2.33M |
|
155
Pediatrix Medical
MD
$2.21B
| $57M | 0.09% |
2,257,595
+866,925
| +62% | +$23.3M |
|
156
Adams Diversified Equity Fund
ADX
$3.08B
| $54.1M | 0.09% |
3,499,654
+444,300
| +15% | +$6.66M |
|
157
RTX Corp
RTX
$295B
| $53.8M | 0.09% |
656,195
-29,663
| -4% | -$2.48M |
|
158
Equinor
EQNR
$90.9B
| $53.2M | 0.09% |
2,690,905
-34,516
| -1% | -$729K |
|
|
FLIR
159
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $53.2M | 0.09% |
983,043
+42,759
| +5% | +$2.17M |
|
160
NXP Semiconductors
NXPI
$65.4B
| $52.8M | 0.09% |
540,956
+171
| +0% | +$16.6K |
|
161
ZTO Express
ZTO
$18.2B
| $52.7M | 0.09% |
2,756,449
-861,568
| -24% | -$16.2M |
|
|
IFN
162
Aberdeen India Fund
IFN
$496M
| $51.2M | 0.08% |
2,404,731
+193,085
| +9% | +$4.12M |
|
163
iShares Core S&P Small-Cap ETF
IJR
$110B
| $50.7M | 0.08% |
648,143
-37,028
| -5% | -$2.87M |
|
164
Nike
NKE
$63.9B
| $50.7M | 0.08% |
603,850
-477,057
| -44% | -$40.1M |
|
|
PACW
165
DELISTED
PacWest Bancorp
PACW
| $49.9M | 0.08% |
1,286,079
-62,195
| -5% | -$2.41M |
|
166
Regions Financial
RF
$26.7B
| $49.7M | 0.08% |
3,329,633
+86,336
| +3% | +$1.27M |
|
167
Coca-Cola Europacific Partners
CCEP
$49.3B
| $48.5M | 0.08% |
858,384
+19,871
| +2% | +$1.09M |
|
|
PSB
168
DELISTED
PS Business Parks, Inc.
PSB
| $47.9M | 0.08% |
284,485
+53,460
| +23% | +$8.55M |
|
|
UN
169
DELISTED
Unilever NV New York Registry Shares
UN
| $47.5M | 0.08% |
781,996
+78,049
| +11% | +$4.67M |
|
|
CMA
170
DELISTED
Comerica
CMA
| $46.5M | 0.08% |
640,433
-1,050,912
| -62% | -$78.1M |
|
171
Ziff Davis
ZD
$1.95B
| $45.8M | 0.07% |
592,841
-112,267
| -16% | -$8.48M |
|
|
CADE
172
DELISTED
Cadence Bancorporation
CADE
| $45.1M | 0.07% |
2,169,577
-173,460
| -7% | -$3.57M |
|
173
Edison International
EIX
$30.7B
| $45M | 0.07% |
667,648
+362,035
| +118% | +$22.5M |
|
174
ExxonMobil
XOM
$634B
| $44.7M | 0.07% |
582,750
+463
| +0.1% | +$35.8K |
|
175
Sysco
SYY
$40.7B
| $44.4M | 0.07% |
628,507
-96,195
| -13% | -$6.85M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2019 Portfolio in Review
As of Q2 2019, Lazard Asset Management held 1,295 positions worth $61.7B, up 0.89% from $61.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $4.01B in Q2 2019, closing 104 positions and reducing 411 holdings. Its most notable exit was Utah Medical Products, an estimated $13.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sabre worth $132M.
- Lazard Asset Management's largest Q2 2019 buy was Sabre: 5,927,264 shares worth $132M.
- Lazard Asset Management added most to Walt Disney in Q2 2019, an estimated $218M increase.
- Lazard Asset Management's biggest Q2 2019 reduction was Wells Fargo, cutting an estimated $505M.
- Lazard Asset Management fully exited Utah Medical Products in Q2 2019, selling an estimated $13.7M.
- Lazard Asset Management's ten largest holdings make up 23% of its $61.7B portfolio in Q2 2019.
- Lazard Asset Management opened 145 new positions and closed 104 in Q2 2019.
- Lazard Asset Management's portfolio value rose 0.89% quarter-over-quarter to $61.7B.
Based on Lazard Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.